Publicacions en col·laboració amb investigadors/es de Centre Hospitalier Regional et Universitaire de Lille (16)

2022

  1. Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcription

    Journal of Clinical Investigation, Vol. 132, Núm. 12

  2. Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects

    Journal of Clinical Investigation, Vol. 132, Núm. 22

2020

  1. Erratum: Gel electrophoresis of human sperm: A simple method for evaluating sperm protein quality (Basic and Clinical Andrology (2018) 28 (10) DOI: 10.1186/s12610-018-0076-0)

    Basic and Clinical Andrology

2018

  1. Gel electrophoresis of human sperm: A simple method for evaluating sperm protein quality

    Basic and Clinical Andrology, Vol. 28, Núm. 1

2017

  1. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology

    Molecular Psychiatry, Vol. 22, Núm. 6, pp. 874-883

2015

  1. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with alzheimer-like Tau pathology

    Human Molecular Genetics, Vol. 24, Núm. 21, pp. 5965-5976

  2. Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms

    Scientific Reports, Vol. 5

2014

  1. Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting

    Journal of Visualized Experiments

  2. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 4, pp. 654-664

2013

  1. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice

    Diabetes, Vol. 62, Núm. 5, pp. 1681-1688

  2. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model

    Aging Cell, Vol. 12, Núm. 1, pp. 11-23

2012

  1. Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S

    Journal of Alzheimer's Disease, Vol. 31, Núm. 4, pp. 741-749

  2. Tau phosphorylation and sevoflurane anesthesia: An association to postoperative cognitive impairment

    Anesthesiology, Vol. 116, Núm. 4, pp. 779-787

2011

  1. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology

    Neurobiology of Disease, Vol. 43, Núm. 2, pp. 486-494

  2. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1812, Núm. 7, pp. 732-742

2010

  1. From tau phosphorylation to tau aggregation: What about neuronal death?

    Biochemical Society Transactions, Vol. 38, Núm. 4, pp. 967-972